Altamira Therapeutics Market Cap

Altamira Therapeutics has a market cap or net worth of $400.08 thousand as of July 15, 2025. Its market cap has decreased by -88.01% in one year.

Market Cap

400.08K

Enterprise Value

-237.49K

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.08

Market Cap Chart

Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 400.08K, a decrease of -99.77%. That is a compound annual growth rate of -42.54%.

Market Cap History

Date	Market Cap	% Change
Jul 14, 2025	400.08K	6.44%
Dec 31, 2024	375.87K	-72.84%
Dec 29, 2023	1.38M	-75.59%
Dec 30, 2022	5.67M	-78.93%
Dec 31, 2021	26.91M	-10.02%
Dec 31, 2020	29.91M	459.11%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.60B
Veradigm	857.64M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
Elite Pharmaceuticals	553.58M
Glass House Brands	545.56M
CytoDyn	394.14M
American Oncology Network	343.79M

Market Cap Rankings